A trial HIV vaccine helps to produce those elusive but crucial antibodies, paving the path for a vaccine that works.

Published Date: 22 May 2024

A small number of individuals participating in a 2019 clinical trial had low levels of an elusive type of broadly neutralizing HIV antibodies in response to an HIV vaccine candidate developed at the Duke Human Vaccine Institute.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

2.

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

3.

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

4.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

5.

Potential new therapy for childhood brain cancer could heal treatment-resistant tumors


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot